目的 探讨超声心动图对缺血性心肌病(ischemic cardiomyopathy,ICM)及扩张型心肌病(dilated cardiomyopathy,DCM) 的鉴别诊断价值。方法 收集175例因心功能不全、射血分数低且超声提示心脏扩张的患者,在纠正心衰后行选择性冠状动脉造影(selective coronary angiography,CAG),明确诊断为ICM或DCM,结果ICM组94例,DCM组81例,应用超声心动图分别对2组从心脏形态学、血流动力学及房室功能等方面进行比较。结果 ICM 组与 DCM 组多项超声指标间差异均有统计学意义(P<0.05或P<0.01)。相对于ICM ,DCM组患者心脏射血分数更低,DCM组的左房内径,右室内径,左室舒张末内径均大于ICM组,同时,DCM组的左室缩末容积及左室舒末容积均大于ICM组,同时,前者的主动脉瓣,肺动脉瓣口血流速度均小于后者。结论 ICM与DCM的心脏结构在超声的显示上有明显不同,前者心脏腔室内径相对较大,且主动脉瓣及肺动脉瓣口血流速度小于后者。
Abstract
Objective To investigate the value of echocardiography in the differential diagnosis of ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM).Methods One hundred and seventy-five cases were enrolled into this study who had been diagnosed with the symptoms of heart failure, low ejection fraction and enlargement of the heart indicated by cardiac ultrasound.After the remission of heart failure,they underwent selective coronary angiography (CAG)and were definitely diagnosed with ICM or DCM. The ICM group consisted of 94 patients and the DCM group 81 patients. Two dimensional color Doppler ultrasound echocardiography was used to find the difference in cardiac morphology, hemodynamics and ventricular function.Results There was significant difference in ultrasound echocardiography between the two groups (P<0.05 or P<0.01).Conclusions There is significant difference between ischemic cardiomyopathy and dilated cardiomyopathy in ultrasound echocardiography. In DCM, the chambers are relatively larger, and blood flow is faster.
关键词
缺血性心肌病 /
扩张型心肌病 /
二维多普勒超声心动图 /
主动脉瓣 /
肺动脉瓣
Key words
ischemic cardiomyopathy /
dilated cardiomyopathy /
two dimensional Doppler echocardiography /
aortic valve /
pulmonary valve
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Schuster A,Morton G,Chiribiri A, et al.Imaging in the management of ischemic ardiomyopathy: special focus on magnetic resonance[J].Am Coll Cardiol,2012, 59(4):359-370.
[2] Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration[J]. Lancet, 1994,344(8922):563-570.
[3] Velazquez E J, Lee K L. Coronary-artery bypass surgery in patients with left ventricular dysfunction[J]. N Engl J Med, 2011,364:1607-1616.
[4] Maron B J, Towbin J A, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention[J]. Circulation, 2006,113(14):1807-1816.
[5] Felker G M, Shaw L K, O'Connor C M. A standardized definition of ischemic cardiomyopathy for use in clinical research[J]. Am Coll Cardiol, 2002,39(2):210-218.
[6] Pinto Y M, Elliott P M, Arbustini E, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases[J]. Eur Heart J, 2016,37(23):1850-1858.
[7] Fihn S D, Blankenship J C. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons[J]. Thorac Cardiovasc Surg,2015,149(3):e5-23.
[8] Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J,2008,29(2):270-276.
[9] Lee D S, Pencina M J, Benjamin E J, et al. Association of parental heart failure with risk of heart failure in offspring[J]. N Engl J Med,2006,355:138-147.
[10] Mahon N G, Murphy R T, MacRae C A, et al.Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease[J]. Ann Intern Med, 2005,143:108-115.
[11] Grunig E, Tasman J A, Kucherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy[J]. J Am Coll Cardiol, 1998,31:186-194.
[12] Michels V V, Moll P P, Miller F A, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy[J]. N Engl J Med, 1992,326:77-82.
[13] Morales A, Hershberger R E. Genetic evaluation of dilated cardiomyopathy[J].Curr Cardiol Rep, 2013,15(7):375.
[14] Gheorghiade M, Sopko G.Navigating the crossroads of coronary artery disease and heart failure[J].Circulation,2006,114:1202-1213.
[15] Hunt S A, Abraham W T, Chin M H, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation[J]. J Am Coll Cardiol,2009,53(15):e1-e90.
[16] Johnson R A. Palacios IDilated cardiomyopathies of the adult (first of two parts) [J]. N Engl J Med, 1982,307(17):1051-1058.
PDF(637 KB)
